Agenda

Accredited by

2023 Texas Lung Cancer Conference Agenda

Event Schedule

Welcome Day

Thursday, March 30, 2023

ACL Live, Keller Pfluger Gallery – Mezzanine Level, 2nd floor

6:00 PM - 9:00 PM

Welcome Reception & Fellows Poster Session

Day One

Friday, March 31, 2023

Breakfast Symposium (Non-CE)

W Hotel, Great Room

8:00 AM - 8:50 AM

Treatment Options For Resectable And PD-L1 <1% Metastatic NSCLC

Ani S. Balmanoukian, MD (The Angeles Clinic, a Cedars Sinai Affiliate)

Early-Stage NSCLC

ACL Live, General Session

9:10 AM

Optimizing Use of Neoadjuvant Immunotherapy in NSCLC

Tina Cascone, MD, PhD (MD Anderson Cancer Center)

9:25 AM

Can We Convert Unresectable to Resectable?

Brendon Stiles, MD (Montefiore Medical Center)

9:40 AM

Current Role of Adjuvant Immunotherapy in NSCLC

Jessica Donington, MD, MSCR (University of Chicago Medicine)

9:55 AM

Current Role of Adjuvant Targeted Therapy in NSCLC

Eric Nadler, MD, MPP (Texas Oncology)

10:10 AM

Best Practices in Unresectable NSCLC

David Spigel, MD (Sarah Cannon Research Institute)

10:25 AM

Q&A

10:40 AM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

10:40 AM - 11:00 AM

Immunotherapy for Advanced NSCLC

ACL Live, General Session

11:00 AM

When is PD(L)1 Monotherapy Enough?

Shirish Gadgeel, MD (Henry Ford Health)

11:10 AM

Advantages of Chemo-Immunotherapy for NSCLC

Melissa Johnson, MD (Sarah Cannon Research Institute)

11:20 AM

The Evolving Role of Dual Checkpoint Inhibition

Hossein Borghaei, DO, MS (Fox Chase Cancer Center)

11:30 AM

Overcoming IO Resistance in NSCLC

Sheena Bhalla, MD (UT Southwestern Medical Center)

11:45 AM

Q&A

12:00 PM

Close

Lunch Symposium (Non-CE)

W Austin Hotel, Great Room

12:00 PM - 12:50 PM

Overcoming Barriers to Peri-operative Treatment in Early-Stage Lung Cancer

MODERATORS: Tina Cascone, MD, PhD (MD Anderson Cancer Center) & Brendon Stiles, MD (Montefiore Medical Center)


PANELISTS: Kristin Higgins, MD (Emory Winship Cancer Institute), Benjamin Levy, MD (Johns Hopkins University) & Jason Porter, MD (West Cancer Center & Research Institute)

SCLC and Mesothelioma

ACL Live, General Session

1:30 PM

Predicting the Future of Limited Stage SCLC

Kristin Higgins, MD (Emory Winship Cancer Institute)

1:40 PM

Best Practice for Extensive Stage SCLC

Lauren Byers, MD (MD Anderson Cancer Center)

1:55 PM

Managing Relapse for Advanced SCLC

Ticiana Leal, MD (Emory Winship Cancer Institute)

2:05 PM

Current Standards in Mesothelioma

Melina Marmarelis, MD, MSCE (University of Pennsylvania)

2:15 PM

Q&A

2:30 PM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

2:30 pm - 2:50 pm

Digital Oncology

ACL Live, General Session

2:50 PM

Telehealth and Oncology: Natural Fit or Arranged Marriage?

Jack West, MD (City of Hope)

3:05 PM

Remote Tobacco Cessation

Randi Williams, PhD, MPH (Georgetown University)

3:20 PM

Mathematical Oncology

Alexander Anderson, PhD (Moffitt Cancer Center)

3:35 PM

The Future of Social Media and Oncology

Narjust Florez (Duma), MD (Dana-Farber Cancer Institute)

3:50 PM

Q&A

4:05 PM

Close

ACL Live, General Session

4:05 PM - 4:50 PM

Surprise Guest Speaker

Day Two

Saturday, April 1, 2023

Breakfast Symposium (Non-CE)

W Hotel, Great Room

8:00 AM - 8:50 AM

It’s Time to Move Forward for Patients With KRAS G12C-Mutated Locally Advanced or Metastatic NSCLC Following First-Line Therapy

Edgardo Santos, MD, FACP (Genesis Care US)

Targeted Therapy: EGFR, HER2

ACL Live, General Session

9:10 AM

Biomarkers: What is NGS?

Christine Lovly, MD, PhD (Vanderbilt University)

9:25 AM

First Line EGFR NSCLC: Is TKI enough?

Sandip Patel, MD (UC San Diego Health)

9:35 AM

Emerging Strategies for EGFR Exon 20

Julia Rotow, MD (Dana-Farber Cancer Institute)

9:50 AM

Overcoming EGFR TKI Resistance

Jonathan Riess, MD, MS (UC Davis Health)

10:05 AM

Targeting HER2 in NSCLC

Estelamari Rodriguez, MD, MPH (University of Miami)

10:15 AM

Refining EGFR Classification

John Heymach, MD, PhD (MD Anderson Cancer Center)

10:25 AM

Q&A

10:40 AM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

10:40 AM - 11:00 AM

Targeted Therapy: Mutations: KRAS/BRAF/MET and ADCs

ACL Live, General Session

11:00 AM

Treating KRAS Mutant NSCLC

Ferdinandos Skoulidis, MD, PhD (MD Anderson Cancer Center)

11:15 AM

Best Practice for BRAF Mutant NSCLC

Ibiayi Dagogo-Jack, MD (Massachusetts General Hospital)

11:25 AM

Current and Future Practice for METex14

Paul Paik, MD (Memorial Sloan Kettering Cancer Center)

11:35 AM

Placing ADCs in the Treatment Algorithm

Joshua Reuss, MD (Georgetown University)

11:45 AM

Q&A

12:00 PM

Close

Lunch Symposium (Non-CE)

W Austin Hotel, Great Room

12:00 PM - 1:00 PM

How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?

Eric Nadler, MD, MPP (Texas Oncology)

Targeted Therapy: Fusions

ACL Live, General Session

1:30 PM

First Line Options for ALK and ROS1 NSCLC

Jason Porter, MD (West Cancer Center)

1:40 PM

Understanding and Overcoming Resistance in ALK/ROS1 NSCLC

Jessica Lin, MD, (Massachusetts General Hospital)

1:55 PM

Targeted Therapy for RET NSCLC

Edgardo Santos, MD, FACP (Genesis Care US)

2:05 PM

NTRK and NRG1 in NSCLC

Yasir Elamin, MD (MD Anderson Cancer Center)

2:15 PM

Q&A

2:30PM

Close

Refreshments & Visit Exhibits (Non-CE)

ACL Live, Music Porch and W Hotel, Prefunction Hall

2:30 pm - 2:50 pm

Refining Practice for the Coming Year

ACL Live, General Session

2:50 PM

Intersection of Community and Academic Oncology

R. Steven Paulson, MD (Texas Oncology)

3:00 PM

How to Incorporate Liquid Biopsy in Practice

Luis Raez, MD (Memorial Cancer Institute)

3:10 PM

Health Care Policy for Today's Oncologist

Debra Patt, MD, PhD (Texas Oncology)

3:20 PM

Q&A

ACL Live, General Session

3:30 PM

Debate Introduction: Is There A Role For CTLA-4 In MNSCLC

Keunchil Park, MD, PhD (MD Anderson Cancer Center)

3:30 PM

Debate: Is there a role for CTLA-4 in mNSCLC (FOR)

Balazs Halmos, MD (Montefiore Medical Center)

3:40 PM

Debate: Is there a role for CTLA-4 in mNSCLC (AGAINST)

Benjamin Levy, MD (Johns Hopkins University)

4:00 PM

Close

ACL Live, General Session

7:00 PM

Farewell Reception

Experience Austin, Texas

Come for the education.

Stay for the fun.

We look forward to hosting a unique conference at the historic venue, ACL Live at the Moody Theater in Austin, Texas.